ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

HLA-DRB1 and DQB1 Amino Acid Mismatches as Determinants of Kidney Allograft Failure

L. Gragert1, K. P. McCullough2, G. L. Wager3, R. Urbanowicz4, R. M. Merion2, M. Kamoun4

1Tulane Cancer Center, Tulane University, New Orleans, LA, 2Arbor Research Collaborative for Health, Ann Arbor, MI, 3Tulane University, New Orleans, LA, 4University of Pennsylvania, Philadelphia, PA

Meeting: 2022 American Transplant Congress

Abstract number: 935

Keywords: HLA matching, HLA-DR antigens, Kidney transplantation, Rejection

Topic: Basic Science » Basic Science » 11 - Histocompatibility and Immunogenetics

Session Information

Session Name: Histocompatibility and Immunogenetics

Session Type: Poster Abstract

Date: Sunday, June 5, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: It was previously reported that HLA-DRB1 amino acid (AA) mismatches (MMs) at peptide-binding pockets of this molecule account for significant incremental risk of kidney graft failure (GF), independent of the long-established association of HLA ABDR antigen (Ag) MMs with GF. We expanded on this prior work by separately examining the incremental risk of graft failure associated with HLA-DRB1 and DQB1 AA MMs beyond that of Ag-level MMs.

*Methods: Data on 141,588 adult-recipient deceased-donor kidney-alone transplants (TXPs) performed between 2000 and 2017 were obtained from the Scientific Registry of Transplant Recipients. We computed DQ Ag MM covering the 2013-2017 TXP period. HLA-A, B, C, DRB1, and DQB1 alleles and corresponding AA polymorphisms were imputed from antigenic specificities using high resolution haplotype frequency data. GF risk was evaluated using Cox proportional-hazards regression models adjusted for covariates including patient and donor risk factors and HLA Ag-level ABDR MMs. Regression results from 10 separate realizations of AA MMs were combined using Rubin’s rules for multiple imputation.

*Results: The impact of HLA-DR Ag MM on GF was replicated; however, HLA-DQ Ag MM was not associated with GF risk after adjusting for ABDR Ag MM (not shown). In contrast, both DRB1 and DQB1 AAMM improved risk stratification after adjusting for ABDR Ag MM. Associations between AAMM and risk of GF are shown during the first year after TXP (Table 1) and after the first year (Table 2), conditional on function at 1 year. DRB1 and DQB1 AAMMs had higher adjusted hazard ratios (HR) during the first year after TXP [DRB1 AA HR 1.12 (1.03-1.21) and DQB1 AA HR 1.08 (95% CI 1.02-1.14)] compared with after the first year after TXP, [DRB1 AA HR 1.03 (0.98-1.08) and DQB1 AA HR 1.04 (1.01-1.08)].

Table 1: GF risk by AAMM (all loci in each model) censored at 1 year after transplant
<1 yr Covariate-adjusted Covariate- and HLA antigen MM-adjusted
HR (per AAMM) 95% CI t and p HR (per AAMM) 95% CI t and p
A 1.00 0.95-1.05 -0.02 and 0.9812 0.97 0.91-1.03 -1.06 and 0.2883
B 0.99 0.93-1.05 -0.33 and 0.7423 0.94 0.88-1.01 -1.66 and 0.0964
C 0.97 0.90-1.03 -0.98 and 0.3262 0.99 0.92-1.06 -0.41 and 0.68
DRB1 1.12 1.04-1.21 2.97 and 0.003 1.12 1.03-1.21 2.56 and 0.0106
DQB1 1.07 1.01-1.14 2.38 and 0.0175 1.08 1.02-1.14 2.51 and 0.0121
Data is with and without adjustment for HLA-A, B and DR antigen-level MMs. Kidney-alone transplants between 2000-2017 with follow-up censored at November 2018.
Table 2: GF risk by AAMM (all loci included in each model) after first year after transplant
1+ yr Covariate-adjusted Covariate- and HLA antigen MM-adjusted
HR (per AAMM) 95% CI t and p HR (per AAMM) 95% CI t and p
A 1.03 1.00-1.06 1.91 and 0.0567 1.00 0.97-1.04 0.08 and 0.9368
B 1.00 0.97-1.03 -0.07 and 0.9414 0.96 0.93-1.00 -2.02 and 0.0435
C 0.96 0.93-1.00 -2.11 and 0.0352 0.99 0.95-1.02 -0.76 and 0.446
DRB1 1.06 1.02-1.11 2.92 and 0.0035 1.03 0.98-1.08 1.23 and 0.2185
DQB1 1.04 1.01-1.08 2.38 and 0.0175 1.04 1.01-1.08 2.38 and 0.0174
Data is with and without adjustment for HLA-A, B and DR antigen-level MMs. Kidney-alone transplants between between 2000-2017 with follow-up censored at November 2018.

*Conclusions: This study of SRTR data shows that during the first year after TXP, both DRB1 and DQB1 AA MMs increase risk of GF, with DRB1 AA MMs having the stronger effect. Discovery of AA MM associations should be validated in future studies based on high resolution genotyping.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Gragert L, McCullough KP, Wager GL, Urbanowicz R, Merion RM, Kamoun M. HLA-DRB1 and DQB1 Amino Acid Mismatches as Determinants of Kidney Allograft Failure [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/hla-drb1-and-dqb1-amino-acid-mismatches-as-determinants-of-kidney-allograft-failure/. Accessed June 6, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences